Expression of bcl-2 antagonist bak in inflammatory and neoplastic skin diseases
- 1 November 1997
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 137 (5) , 703-708
- https://doi.org/10.1111/j.1365-2133.1997.tb01105.x
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Induction of apoptosis by the Bcl-2 homologue BakNature, 1995
- Modulation of apoptosis by the widely distributed Bcl-2 homologue BakNature, 1995
- Cloning of a bcl-2 homologue by interaction with adenovirus E1B 19KNature, 1995
- Abnormal Bcl-2 and “Tissue” Transglutaminase Expression in Psoriatic SkinJournal of Investigative Dermatology, 1994
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- Continuous c-fos expression precedes programmed cell death in vivoNature, 1993
- The role of c-myc in cell growthCurrent Opinion in Genetics & Development, 1993
- Patterns of cell death: the significance of apoptosis for dermatologyExperimental Dermatology, 1993
- Induction of apoptosis in fibroblasts by c-myc proteinCell, 1992
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991